Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

GlaxoSmithKline Consumer Healthcare - Sri Lanka, (GSK), makers of Panadol is constructing a new Panadol production plant which will be located next to its present pharmaceutical operation at Moratuwa.

Dove and PG Tips - would add Sensodyne toothpaste and Panadol to its list of household brands. Such a deal would be one of the biggest ever involving London-listed firms. GSK said in a statement ...

Pfizer is looking to sell about 700 million ordinary shares in Haleon , its bookrunner J.P. Morgan said on Tuesday, lowering ...

GSK boss Emma Walmsley is selling the company's consumer healthcare division, which makes big-brand products including Sensodyne and Panadol. That move is designed to let it focus on developing ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

The objective was to raise awareness of the product and triple its effectiveness. We showed Panadol's understanding of tough people and their tough pain. We showcased interesting and likeable people ...

Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units. The company makes a wide range of ...

Pain relief medication brand Panadol used video content to shift perceptions to being 'tough' on pain across the Arabia region. Panadol was the pain-relief category leader and it had successfully ...

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 ...